Showing results (61-70 of 129) with videos related to
Sort By:
Pageof 13
The American Journal of Managed Care|November 17, 2011
Compliance and persistence with concomitant statin and oral antihyperglycemic therapyQiaoyi Zhang, Changgeng Zhao, Michael J Davies, et al.Cardiovascular Diabetology|April 23, 2010
Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort studyAlex Z Fu, Ying Qiu, Larry Radican, et al.Diabetes, Obesity & Metabolism|June 16, 2021
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United StatesXi Tan, Lingfeng Yang, Kamlesh Khunti, et al.American Health & Drug Benefits|February 7, 2018
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication UseYuexin Tang, Xingyue Huang, Jinan Liu, et al.Pharmacoepidemiology and Drug Safety|May 8, 2024
Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post-authorization safety studySoulmaz Fazeli Farsani, Kristy Iglay, Ling Zhang, et al.Drugs & Aging|April 24, 2013
Sulfonylureas and risk of falls and fractures: a systematic reviewKate L Lapane, Shibing Yang, Monique J Brown, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2018
Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes MellitusYuexin Tang, Jinan Liu, Hakima Hannachi, et al.Therapeutic Advances in Gastroenterology|February 17, 2022
Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic reviewPradeep Rajan, Kristy Iglay, Thomas Rhodes, et al.Current Medical Research and Opinion|May 14, 2016
Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureasKristy Iglay, Ying Qiu, Chun-Po Steve Fan, et al.Expert Review of Pharmacoeconomics & Outcomes Research|June 28, 2016
Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titrationPedro A Laires, Jackson Tang, Chun Po Steve Fan, et al.Pageof 13